Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the effect of NPL-2003 on the symptoms of Obsessive Compulsive Disorder (OCD) in an adolescent population.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Neuropharm
NCT06934525 · Obsessive Compulsive Disorder (OCD), Pediatric Anxiety Disorders, and more
NCT04631042 · Typical Development, Obsessive Compulsive Disorder, and more
NCT07255131 · Depression - Major Depressive Disorder, Anxiety Chronic, and more
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
NCT07011901 · Obsessive Compulsive Disorder
New York State Psychiatric Institute, Columbia University
New York, New York
University Hospitals Case Medical Center
Cleveland, Ohio
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions